The major representatives of the RAS gene family, namely HRAS, KRAS and NRAS, are the most frequently mutated genes in malignant neoplasms, and have been under the spotlight of scientific research for the development of targeted therapies [22]. The gene discussed is HRAS; the disease is cancer.